Postoperative pulmonary complications

A Miskovic, AB Lumb - BJA: British Journal of Anaesthesia, 2017 - academic.oup.com
Postoperative pulmonary complications (PPCs) are common, costly, and increase patient
mortality. Changes to the respiratory system occur immediately on induction of general …

Perioperative pulmonary atelectasis-part II: clinical implications

D Lagier, C Zeng, A Fernandez-Bustamante… - …, 2022 - pmc.ncbi.nlm.nih.gov
The development of pulmonary atelectasis is common in the surgical patient. Pulmonary
atelectasis can cause various degrees of gas exchange and respiratory mechanics …

Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study

E Kirmeier, LI Eriksson, H Lewald… - The Lancet …, 2019 - thelancet.com
Background Results from retrospective studies suggest that use of neuromuscular blocking
agents during general anaesthesia might be linked to postoperative pulmonary …

Current status of neuromuscular reversal and monitoring: challenges and opportunities

SJ Brull, AF Kopman - Survey of Anesthesiology, 2017 - journals.lww.com
Patients undergoing inpatient surgeries were assessed. Absolute thresholds were
established by the lowest mean arterial pressure (MAP) maintained for various durations …

Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications.

DJ McLean, D Diaz-Gil, HN Farhan, KS Ladha… - …, 2015 - europepmc.org
Background Duration of action increases with repeated administration of neuromuscular-
blocking agents, and intraoperative use of high doses of neuromuscular-blocking agent may …

Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study

B Brueckmann, N Sasaki, P Grobara… - BJA: British Journal …, 2015 - academic.oup.com
Background This study aimed to investigate whether reversal of rocuronium-induced
neuromuscular blockade with sugammadex reduced the incidence of residual blockade and …

Nondepolarizing neuromuscular blocking agents, reversal, and risk of postoperative pneumonia

CM Bulka, MA Terekhov, BJ Martin… - …, 2016 - ingentaconnect.com
Background: Residual postoperative paralysis from nondepolarizing neuromuscular
blocking agents (NMBAs) is a known problem. This paralysis has been associated with …

Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials

M Carron, F Zarantonello, P Tellaroli, C Ori - Journal of clinical anesthesia, 2016 - Elsevier
Background and objective Sugammadex has been introduced for reversal of rocuronium (or
vecuronium)–induced neuromuscular blockade (NMB). Although its efficacy has been …

A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade

A Abad‐Gurumeta, J Ripollés‐Melchor… - …, 2015 - Wiley Online Library
We reviewed systematically sugammadex vs neostigmine for reversing neuromuscular
blockade. We included 17 randomised controlled trials with 1553 participants. Sugammadex …

Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation

JM Hunter - BJA: British Journal of Anaesthesia, 2017 - academic.oup.com
The use of anticholinesterases to reverse residual neuromuscular block at the end of
surgery became routine practice in the 1950s. These drugs could only be used when …